The present disclosure pertains to medical devices, and methods for manufacturing and using medical devices. More particularly, the disclosure is directed to stents for implantation in a body lumen, and associated methods.
Implantable medical devices (e.g., expandable stents) may be designed to treat a variety of medical conditions in the body. For example, some expandable stents may be designed to radially expand and support a body lumen and/or provide a fluid pathway for digested material, blood, or other fluid to flow therethrough following a medical procedure. Some medical devices may include radially or self-expanding stents which may be implanted transluminally via a variety of medical device delivery systems. These stents may be implanted in a variety of body lumens such as coronary or peripheral arteries, the esophageal tract, gastrointestinal tract (including the intestine, stomach and the colon), tracheobronchial tract, urinary tract, biliary tract, vascular system, etc.
In some instances it may be desirable to design stents to include sufficient flexibility while maintaining sufficient radial force to open the body lumen at the treatment site. However, in some stents, the compressible and flexible properties that assist in stent delivery may also result in a stent that has a tendency to migrate from its originally deployed position. For example, stents that are designed to be positioned in the esophageal or gastrointestinal tract may have a tendency to migrate due to peristalsis (i.e., the involuntary constriction and relaxation of the muscles of the esophagus, intestine, and colon which push the contents of the canal therethrough). Additionally, the generally moist and inherently lubricious environment of the esophagus, intestine, colon, etc. further contributes to a stent's tendency to migrate when deployed therein.
Therefore, in some instances it may be desirable to design a stent with anti-migration features to reduce the stent's tendency to migrate. Examples of medical devices including anti-migration features are disclosed herein.
This disclosure provides design, material, manufacturing method, and use alternatives for medical devices. As an example, a stent includes an elongated tubular member expandable from a radially collapsed configuration to a radially expanded configuration, the elongate tubular member including at least one filament, the elongated tubular member including a first segment in which the at least one filament is knitted into a first knitted pattern providing the first segment with a first performance characteristic and a second segment in which the at least one filament is knitted into a second knitted pattern providing the second segment with a second performance characteristic different from the first performance characteristic. Either the first knitted pattern or the second knitted pattern includes an anti-migration feature.
Additionally or alternatively, the anti-migration feature may include a plurality of anti-migration loops formed from the at least one filament, and when the plurality of anti-migration loops are included as part of the first knitted pattern, the first segment may be adapted such that the plurality of anti-migration loops retract into the first knitted pattern in response to the stent being placed in axial tension.
Additionally or alternatively, the anti-migration feature may include a plurality of anti-migration loops formed from the at least one filament, and when the plurality of anti-migration loops are included as part of the second knitted pattern, the second may be is adapted such that the second segment retains the plurality of anti-migration loops in response to the stent being placed in axial tension.
Additionally or alternatively, the first segment may include a first plurality of rows in which the filament is knitted into the first knitting pattern, the first plurality of rows extending circumferentially around a longitudinal axis of the elongated tubular member.
Additionally or alternatively, at least some rows of the first plurality of rows may include a plurality of twisted knit stitches with intermediate rung portions extending between adjacent twisted knit stitches.
Additionally or alternatively, the second segment may include a second plurality of rows in which the filament may be knitted into the second knitting pattern, the second plurality of rows extending circumferentially around the longitudinal axis of the elongated tubular member.
Additionally or alternatively, at least some rows of the second plurality of rows may include a plurality of stitches in which each stitch may include a loop that passes around a corresponding loop in a previous row without twisting.
Additionally or alternatively, the elongated tubular member may further include a third segment in which the at least one filament may be knitted into a knitted pattern that is the same as the first knitted pattern or the second knitted pattern.
Additionally or alternatively, the first segment may be disposed between the second knitted segment and the third knitted segment, and the filament may be knitted into the second knitted pattern within the third segment.
Additionally or alternatively, the second segment may be disposed between the first knitted segment and the third knitted segment, and the filament may be knitted into the first knitted pattern within the third segment.
Additionally or alternatively, the anti-migration feature may include a flared end.
As another example, a stent includes an elongated tubular member expandable from a radially collapsed configuration to a radially expanded configuration, the elongate tubular member including at least one filament, the elongated tubular member including a first segment in which the at least one filament is knitted into a first knitted pattern and a second segment in which the at least one filament is knitted into a second knitted pattern. A plurality of anti-migration loops are formed from the at least one filament within the first segment. The first knitted pattern is adapted to enable elongation of the first segment when the elongated tubular member is subjected to axial tension, thereby allowing the plurality of anti-migration loops to retract into the first knitted pattern. The second knitted pattern is adapted to restrict elongation of the second segment when the elongated tubular member is subjected to axial tension.
Additionally or alternatively, the first segment, including the plurality of anti-migration loops, may be flared.
Additionally or alternatively, the second segment may be flared.
Additionally or alternatively, the stent may further include one or more additional segments, in addition to the first segment and the second segment, wherein in each of the one or more additional segments, the at least one filament may be knitted into knitting patterns matching either the first knitting pattern or the second knitting pattern.
Additionally or alternatively, the stent may further include a third segment, wherein the second segment may be positioned between the first segment and the third segment, wherein the one or more filaments may be knitted into the first knitting pattern in the third segment, and wherein the third segment may include a plurality of anti-migration loops formed from the at least one filament
In another example, a stent includes an elongated tubular member expandable from a radially collapsed configuration to a radially expanded configuration, the elongate tubular member including at least one filament, the elongated tubular member including a first segment in which the at least one filament is knitted into a first knitted pattern and a second segment in which the at least one filament is knitted into a second knitted pattern. A plurality of anti-migration loops are formed within the second segment from the at least one filament. The first knitted pattern is adapted to enable elongation of the first segment when the elongated tubular member is subjected to axial tension and the second knitted pattern is adapted to restrict elongation of the second segment when the elongated tubular member is subjected to tension, thereby retaining the plurality of anti-migration loops.
Additionally or alternatively, the first segment may be flared.
Additionally or alternatively, the second segment may be flared.
Additionally or alternatively, the stent may further include a third segment in which the one or more filaments may be knitted into the second knitting pattern, the third segment may include a plurality of anti-migration loops formed from the at least one filament.
The above summary of some embodiments is not intended to describe each disclosed embodiment or every implementation of the present disclosure. The Figures, and Detailed Description, which follow, more particularly exemplify these embodiments.
The invention may be more completely understood in consideration of the following detailed description of various embodiments of the invention in connection with the accompanying drawings, in which:
While the disclosure is amenable to various modifications and alternative forms, specifics thereof have been shown by way of example in the drawings and will be described in detail. It should be understood, however, that the intention is not to limit the disclosure to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the disclosure.
For the following defined terms, these definitions shall be applied, unless a different definition is given in the claims or elsewhere in this specification.
All numeric values are herein assumed to be modified by the term “about,” whether or not explicitly indicated. The term “about” generally refers to a range of numbers that one of skill in the art would consider equivalent to the recited value (i.e., having the same function or result). In many instances, the terms “about” may include numbers that are rounded to the nearest significant figure.
The recitation of numerical ranges by endpoints includes all numbers within that range (e.g. 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, and 5).
As used in this specification and the appended claims, the singular forms “a”, “an”, and “the” include plural referents unless the content clearly dictates otherwise. As used in this specification and the appended claims, the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
The following detailed description should be read with reference to the drawings in which similar elements in different drawings are numbered the same. The drawings, which are not necessarily to scale, depict illustrative embodiments and are not intended to limit the scope of the invention.
In some instances, it may be desirable to provide an endoluminal implant, or stent, that can deliver luminal patency in a patient with an esophageal stricture or other medical condition. Such stents may be used in patients experiencing dysphagia, sometimes due to esophageal cancer. An esophageal stent may allow a patient to maintain nutrition via oral intake during cancer treatment or palliation periods. Some stents have a woven or knitted configuration to provide good radial strength with minimal foreshortening which may be desirable in esophageal and trachea-bronchial applications as well as some post-bariatric surgery applications. While the embodiments disclosed herein are discussed with reference to esophageal stents, it is contemplated that the stents described herein may be used and sized for use in other locations such as, but not limited to: bodily tissue, bodily organs, vascular lumens, non-vascular lumens and combinations thereof, such as, but not limited to, in the coronary or peripheral vasculature, trachea, bronchi, colon, small intestine, biliary tract, urinary tract, prostate, brain, stomach and the like.
The stent 10 may be expandable from a first radially collapsed configuration (not explicitly shown) to a second radially expanded configuration. In some cases, the stent 10 may be deployed to a configuration that is between the collapsed configuration and the expanded configuration, i.e., the stent 10 may be deployed having a deployed diameter that is greater than a diameter of the stent 10 or a particular portion thereof while in its collapsed configuration yet less than a diameter of the stent 10 or a particular portion thereof while in its fully expanded configuration. In some cases, the anatomy in which the stent 10 is deployed may influence its deployed configuration. For example, if the anatomy in which the stent 10 is to be deployed has a diameter that is less than a diameter of the stent 10 or a particular portion thereof when fully expanded, the stent 10 may have a deployed diameter that is intermediate its collapsed configuration diameter and its fully expanded configuration diameter.
The stent 10 may be formed of one or more, or a plurality of interwoven filaments. For example, the stent 10 may have a knitted structure, fabricated from one or more filaments interwoven with each other. In some cases, the stent 10 may have a knitted structure that is formed by knitting a single filament extending the entire length of the stent. In some cases, the stent 10 may be knitted from one or more filaments that are knitted together using two or more different knitting patterns. For example, the first section 12 may be formed by knitting together one or more filaments in a first knitting pattern while the second section 14 may be formed by knitting together one or more filaments in a second knitting pattern that is different from the first knitting pattern. The same filament(s) may be used throughout both the first knitting pattern in the first section 12 and the second knitting pattern in the second section 14, or different filaments may be used throughout each of the first knitting pattern in the first section 12 and the second knitting pattern in the second section 14. As will be discussed, each of the first knitting pattern and the second knitting pattern, and optionally any other knitting patterns used in forming the stent 10, may provide unique properties to the particular part of the stent 10 that is formed using those particular knitting patterns.
In some cases, the filament(s) of the stent 10 may be formed of a monofilament, while in other cases the stent 10 may be formed of two, three or more filaments that are wound, braided, or woven together prior to knitting the stent 10. In some instances, an inner surface and/or an outer surface of the stent 10 may be entirely, substantially, or partially covered with a polymeric covering or coating. The covering or coating may span the open spaces that are formed by the filament being knitted together. The covering or coating may help reduce food impaction and/or tumor or tissue ingrowth, for example.
It will be appreciated that in many cases, the performance demands on a stent, such as the stent 10, can be conflicting. For example, strength versus flexibility is a common conflict in designing medical devices such as stents. Constructing a stent that will remain in place, and not migrate, can conflict with a desire to possibly be able to move or even remove a stent. By forming the stent 10 having multiple sections such as the first section 12 and the second section 14 with differing knitting patterns, and thus with possibly differing performance characteristics, can help to provide the best of both worlds, as it were. As will be discussed subsequently, the knitting patterns disclosed herein can be used to form various sections or portions of the stent 10 in order to provide a desired combination of characteristics to the stent 10.
It is contemplated that the filament(s) of the stent 10 may be made from a number of different materials such as, but not limited to, metals, metal alloys, shape memory alloys and/or polymers, as desired, enabling the stent 10 to be expanded into shape when accurately positioned within the anatomy. In some instances, the material may be selected to enable the stent 10 to be removed with relative ease as well. For example, the stent 10 may be formed from alloys such as, but not limited to, Nitinol and Elgiloy®. Depending on the material selected for construction of the stent 10, the stent 10 may be self-expanding, i.e., configured to automatically radially expand when unconstrained. In some instances, the stent 10 may not be self-expanding, and thus may not regain its fully expanded configuration without the assistance of an expansion device such as but not limited to an inflatable balloon disposed within the lumen 22. As used herein, the term “self-expanding” refers to the tendency of the stent 10 to return to a preprogrammed diameter when unrestrained by an external biasing force, e.g., a delivery catheter or sheath. While not shown, the stent 10 may include a one-way valve, such as an elastomeric slit valve or duck bill valve, positioned within the lumen 20 in order to prevent retrograde flow of gastrointestinal fluids, for example.
In some instances, in the radially expanded configuration, the stent 10 may include a first end region 24 proximate the first end 16 and a second end region 26 proximate the second end 18. In some cases, the first end region 24 and the second end region 28 may include retention features or anti-migration flared regions (not explicitly shown) having enlarged diameters relative to the intermediate region 20. The anti-migration flared regions, which may be positioned adjacent to the first end 16 and/or the second end 18, may be configured to engage an interior portion of the walls of the esophagus or other body lumen. In some cases, the retention features, or flared regions, may have a larger diameter than the intermediate region 20 of the stent 10 in order to prevent the stent 10 from migrating once placed in the esophagus or other body lumen. In some instances, a transition from the cross-sectional area of the intermediate region 20 to the retention features or flared regions may be gradual, sloped, or occur in an abrupt step-wise manner, as desired.
In some instances, the first anti-migration flared region may have a first outer diameter and the second anti-migration flared region may have a second outer diameter. In some instances, the first and second outer diameters may be approximately the same, while in other instances, the first and second outer diameters may be different. In some cases, the stent 10 may include only one or none of the anti-migration flared regions. For example, the first end region 24 may include an anti-migration flare while the second end region 26 may have an outer diameter similar to the intermediate region 20. It is further contemplated that the second end region 26 may include an anti-migration flare while the first end region 24 may have an outer diameter similar to an outer diameter of the intermediate region 20. In some embodiments, the stent 10 may have a uniform outer diameter from the first end 16 to the second end 18. In some embodiments, the outer diameter of the intermediate region 20 may be in the range of 15 to 25 millimeters in the fully expanded configuration. The outer diameter of the anti-migration flares may be in the range of 20 to 30 millimeters in the fully expanded configuration. It is contemplated that the outer diameter of the stent 10 may be varied to suit the desired application.
In some cases, composite filaments may be used to make the stent 10, which may include, for example, an outer shell or cladding made of Nitinol and a core formed of platinum or other radiopaque material. It is further contemplated that the stent 10 may be formed from polymers including, but not limited to, polyethylene terephthalate (PET). In some instances, the filaments of the stent 10, or portions thereof, may be bioabsorbable or biodegradable, while in other instances the filaments of the stent 10, or portions thereof, may be biostable.
The uppermost, or first, row 34a may be unsecured and active. In some instances, the first row 34a may include a plurality of loops 38, individually labeled as 38a, 38b, 38c. The loops 38 may each include a loop portion 40, individually labeled as 40a, 40b, 40c. The loops 38 may each include an overlapping base portion 42, individually labeled as 42a, 42b, 42c. The overlapping base portion 42 is understood to be the portion of the loops 38 in which one segment of the filament 32 overlaps or crosses over a second segment of the filament 32, with the segment of the filament forming the loop portion 40 extending therebetween. Adjacent loops 38 may be interconnected by a rung section 44, individually labeled as 44a, 44b. For example, a first rung section 44a may extend between the base portion 42a of the first loop 38a and the second base portion 42b of the second loop 38b.
The next row 34b may be suspended from the loops 38 of the first row 34a. For example, the second row 34b may include a plurality of loops 46, individually labeled as 46a, 46b, 46c. Each loop 46 includes a loop portion 48, individually labeled as 48a, 48b, 48c, and a base portion 50, individually labeled as 50a, 50b, 50c. Adjacent loops 46 may be interconnected by a rung section 52, individually labeled as 52a, 52b. As the stent 10, or at least the first section 12, is knitted, the loop portion 48 may be wrapped around the base portion 42 of the preceding row 34a. Thus, each loop 46 of a given row may be wrapped around the base portion 42 of a loop 38 of the preceding row.
It is contemplated that a single row 34 may be formed at a time. For example, the rows 34 may be formed in succession with a subsequent row, e.g., row 34b, being formed after the preceding row, e.g., row 34a, has formed a complete rotation about the stent 10. While not explicitly shown, the loops 38 of the first row 34a may be wrapped about a section of the filament 32 free from loops. As described herein, the loops 46 of the second row 34b may be wrapped about the base portion 42 of the loops 38 of the preceding row 34a. For example, the filament 32 may be knitted such that it extends from the first rung section 52a, is wrapped about the base portion 42a of the preceding row 34a, crosses back over itself to form base section 50b and continues to the next rung section 52b.
The first knitting pattern 30 provides the stent 10, or at least the first section 12 formed using the first knitting pattern 30, with particular performance characteristics. In some cases, the first knitting pattern 30 provides the stent 10, or at least the first section 12, with good radial strength and axial flexibility. The first knitting pattern 30 provides the stent 10, or at least the first section 12, with an ability to easily lengthen in response to the stent 10 being placed into tension. The loops such as the loops 38 and the loops 46 lengthen as the corresponding rungs 44 and 52 shorten, respectively. In cases where the first knitting pattern 30 includes one or more anti-migration loops, which are easily formed when knitting the first knitting pattern 30, applying a tensile force to the stent 10 causes the first section 12 to elongate, and causes the anti-migration loops to pull out. This means that the stent 10 can include anti-migration loops, in addition to or instead of including one or more flared retention regions, yet allow easy repositioning or even removal of the stent 10 by simply applying a tensile force to the first section 12, thereby causing the stent 10 to elongate and to pull out the anti-migration loops. Additional details regarding the first knitting pattern 30 may be found in US 2019/0307586, which application is incorporated by reference herein.
In some applications, the stent 10 may be positioned within the anatomy at a location in which the stent 10 may be subjected to significant peristaltic motion. In situations such as this, the flexibility enabled by the first knitting pattern 30 may permit the stent 10 to bend and flex in response to the underlying pressure waves without causing the stent 10 to move within the anatomy. In some applications, there may be a desire to provide the stent 10 with other properties, such as but not limited to anti-migration loops that do not easily pull out in response to a tensile force.
The uppermost, or first, row 62a may be unsecured and active. In some instances, the first row 62a may include a plurality of open loops 64, individually labeled as 64a, 64b, 64c. Each open loop 64 is joined to an adjoining open loop 64 via a rung 66, individually labeled as 66a and 66b. The next row, row 62b, includes a plurality of open loops 68, individually labeled as 68a, 68b, 68c. Each open loop 68 is joined to an adjoining loop open 68 via a rung 70, individually labeled as 70a and 70b. The next row, row 62c, includes a plurality of open loops 72, individually labeled as 72a, 72b, 72c. Each open loop 72 is joined to an adjoining loop 72 via a rung 74, individually labeled as 74a and 74b. An open loop, is a loop in which the base of the loop is not twisted (i.e., does not include segments if the filament forming the loop that cross over one another).
In forming the second knitting pattern 60, the filament 32 (a length of the filament 32 forming the first knitting pattern 30) forms a first row of a plurality of open loops 64 with rungs 66 extending between adjacent open loops 64. In the next successive circumferential row, the open loops 68 extend around the open base of the open loops 64 of the previous row, with rungs 70 extending between adjacent open loops 68. In the next successive circumferential row, the open loops 72 extend around the open base of the open loops 68 of the previous row. This pattern continues, with each successive circumferential row until sufficient rows 62 are completed so that the stent 10, or at least the second section 14, has achieved a desired length.
The second knitting pattern 60 provides the stent 10, or at least the second section 14 formed using the second knitting pattern 60, with particular performance characteristics. For example, the second knitting pattern 60 does not readily purse down or radially constrain when being removed or repositioned. This is because connected loops need to share a single rung in order to elongate. Each loop is on contention, which thus negates the ability of the second knitting pattern 60 to elongate, or at least to substantially elongate. As a result, if the second section 14 includes anti-migration loops, the anti-migration loops do not pull out in response to applying a tensile force to the stent 10.
Because the first knitting pattern 30 and the second knitting pattern 60 have different performance characteristics, including how they respond to an applied tensile strength and what that means for any anti-migration loops formed within either of the first knitting pattern 30 or the second knitting pattern 60, there can be advantages to using both the first knitting pattern 30 and the second knitting pattern 60 within the same stent 10.
In some cases, a stent formed using the composite knitting pattern 80 may include only a relatively small second segment 84 employing the first knitting pattern 30 while the first segment 82 and the third segment 86, both employing the second knitting pattern 60, may extend to the opposing ends of the stent. This would provide a stent that had two large segments that were less flexible, and less responsive to applied tensile forces, and one small segment that was more flexible and more responsive to applied tensile forces. It will be appreciated that the composite knitting pattern 80 shown in
Use of a stent such as the stent 90 may be beneficial for treatment of conditions in which the stent may benefit from the presence of anti-migration loops such as the anti-migration loops 98, but device removal would be sensitive to the continued presence of the anti-migration loops 98. An example would be bariatric surgical leak treatments. By placing the anti-migration loops 98 within the second segment 94, which represents the first knitting pattern 30, this problem is avoided.
In some cases, a stent may include multiple regions formed of the first knitting pattern 30, with each of the multiple regions including anti-migration loops.
Because the stent 110 and the stent 110a have their anti-migration loops 122, 122a and 124, 124a formed within portions of the stent 110, 110a that employ the first knitting pattern 30, it will be appreciated that
As seen in
It should be understood that this disclosure is, in many respects, only illustrative. Changes may be made in details, particularly in matters of shape, size, and arrangement of steps without exceeding the scope of the disclosure. This may include, to the extent that it is appropriate, the use of any of the features of one example embodiment being used in other embodiments. The invention's scope is, of course, defined in the language in which the appended claims are expressed.
This application claims the benefit of U.S. Provisional Patent Application Ser. No. 63/301,731, filed Jan. 21, 2022, which is incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
63301731 | Jan 2022 | US |